Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D'Andrea

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
European Urology|August 4, 2018
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 TrialDavid D'Andrea, Shahrokh F Shariat, Francesco Soria
BJU International|April 25, 2025
The challenges of conducting a surgical trial-reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialStephan Brönimann, Altug Tuncel, Rodolfo Hurle, et al.
European Urology|July 25, 2024
Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 TrialStefano Mancon, Francesco Soria, Benjamin Pradere, et al.
Current Opinion in Urology|January 17, 2025
Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer?Anna Cadenar, Stefano Mancon, Shahrokh F Shariat, et al.
Translational Andrology and Urology|April 13, 2019
Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?David D'Andrea, Paolo Gontero, Shahrokh F Shariat, et al.
Current Opinion in Urology|May 9, 2021
The prognostic value of sarcopenia in patients with prostate cancer: a systematic reviewVictoria Jahrreiss, Ekaterina Laukhtina, David D'Andrea, et al.
Current Opinion in Urology|April 3, 2020
Ureteral and urethral recurrence after radical cystectomy: a systematic reviewRoberto Carando, Shahrokh F Shariat, Marco Moschini, et al.
European Urology Focus|April 20, 2021
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9Francesco Soria, David D'Andrea, Paolo Gontero, et al.
European Urology|April 23, 2026
Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. 2026David D'Andrea, Francesco Soria, Paolo Gontero, et al.
Translational Andrology and Urology|November 22, 2021
Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literatureKilian M Gust, Irene Resch, David D'Andrea, et al.
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
European Urology|August 4, 2018
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 TrialDavid D'Andrea, Shahrokh F Shariat, Francesco Soria
BJU International|April 25, 2025
The challenges of conducting a surgical trial-reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialStephan Brönimann, Altug Tuncel, Rodolfo Hurle, et al.
European Urology|July 25, 2024
Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 TrialStefano Mancon, Francesco Soria, Benjamin Pradere, et al.
Current Opinion in Urology|January 17, 2025
Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer?Anna Cadenar, Stefano Mancon, Shahrokh F Shariat, et al.
Translational Andrology and Urology|April 13, 2019
Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?David D'Andrea, Paolo Gontero, Shahrokh F Shariat, et al.
Current Opinion in Urology|May 9, 2021
The prognostic value of sarcopenia in patients with prostate cancer: a systematic reviewVictoria Jahrreiss, Ekaterina Laukhtina, David D'Andrea, et al.
Current Opinion in Urology|April 3, 2020
Ureteral and urethral recurrence after radical cystectomy: a systematic reviewRoberto Carando, Shahrokh F Shariat, Marco Moschini, et al.
European Urology Focus|April 20, 2021
Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9Francesco Soria, David D'Andrea, Paolo Gontero, et al.
European Urology|April 23, 2026
Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. 2026David D'Andrea, Francesco Soria, Paolo Gontero, et al.
Translational Andrology and Urology|November 22, 2021
Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literatureKilian M Gust, Irene Resch, David D'Andrea, et al.
Pageof 24